Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page
- Check5 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5, reflecting a small internal update to the page metadata. This indicates a housekeeping patch rather than a substantive change to study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing v3.6.3, indicating a new site build without changing study details or data.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2 as part of a small site update.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0, signaling a software or CMS update for the page rather than a modification to the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study page now indicates recruitment is closed to new participants and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention label formatting and notes Revision: v3.6.0.SummaryDifference0.4%

- Check70 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the entry. This change represents an internal version bump and does not modify the study details presented.SummaryDifference0.1%

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.